Literature DB >> 19434034

Management of infective endocarditis in outpatients: clinical experience with outpatient parenteral antibiotic therapy.

Julius Larioza1, Lena Heung, Amy Girard, Richard B Brown.   

Abstract

BACKGROUND: There is limited experience in treating infective endocarditis (IE) with outpatient parenteral antibiotic therapy (OPAT).
METHODS: Following institutional review board (IRB) approval, patients discharged from Baystate Medical Center with IE documented by modified Duke criteria treated with OPAT were identified. Data obtained included organisms implicated, indications of clinical stability, percentage of total therapy rendered after hospitalization, and one year follow up.
RESULTS: Forty-three patients met criteria. Thirty-five percent were infected with staphylococci; 38% harbored streptococci or enterococci. Native valves and left-sided valves each constituted approximately 75% of total. All patients received >4 weeks of therapy, with >66% rendered after hospital discharge A median of 7 days of hemodynamic stability and negative blood cultures occurred prior to discharge. After one year, no patients died from IE. Twenty-three percent were hospitalized during OPAT from intravenous catheter, antibiotic, or other complications, but none for direct complications of IE.
CONCLUSIONS: OPAT for IE can be safely utilized, and at least 66% of care can be given in this manner. Our investigation provides enhanced data on employing OPAT for IE caused by staphylococci, left-sided infections, and also provides outcomes after one year after treatment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19434034     DOI: 10.1097/SMJ.0b013e3181a4eef2

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  7 in total

1.  Outpatient parenteral antimicrobial therapy.

Authors:  Kevin B Laupland; Louis Valiquette
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

Review 2.  Outpatient parenteral antimicrobial therapy with ceftriaxone, a review.

Authors:  Christopher J A Duncan; David A Barr; R Andrew Seaton
Journal:  Int J Clin Pharm       Date:  2012-04-17

3.  Connected care for endocarditis and heart failure patients: a hospital-at-home programme.

Authors:  J van Ramshorst; M Duffels; S P M de Boer; A Bos-Schaap; O Drexhage; S Walburg; J de Beij; D van der Stoop; V A W M Umans
Journal:  Neth Heart J       Date:  2021-09-15       Impact factor: 2.854

Review 4.  Clinical and cost-effectiveness, safety and acceptability of community intravenous antibiotic service models: CIVAS systematic review.

Authors:  E D Mitchell; C Czoski Murray; D Meads; J Minton; J Wright; M Twiddy
Journal:  BMJ Open       Date:  2017-04-20       Impact factor: 2.692

5.  Benefit of Echocardiography in Patients With Staphylococcus aureus Bacteremia at Low Risk of Endocarditis.

Authors:  George S Heriot; Steven Y C Tong; Allen C Cheng; Danny Liew
Journal:  Open Forum Infect Dis       Date:  2018-12-11       Impact factor: 3.835

6.  Outpatient Parenteral Antibiotic Treatment vs Hospitalization for Infective Endocarditis: Validation of the OPAT-GAMES Criteria.

Authors:  Juan M Pericàs; Jaume Llopis; Patricia Muñoz; Víctor González-Ramallo; M Eugenia García-Leoni; Arístides de Alarcón; Rafael Luque; M Carmen Fariñas; Miguel Á Goenaga; Marta Hernández-Meneses; David Nicolás; Antonio Ramos-Martínez; M Ángeles Rodríguez-Esteban; Aroa Villoslada-Gelabert; José M Miró
Journal:  Open Forum Infect Dis       Date:  2022-08-30       Impact factor: 4.423

7.  Risk factors for failure of outpatient parenteral antibiotic therapy (OPAT) in infective endocarditis.

Authors:  Christopher J A Duncan; David A Barr; Antonia Ho; Emma Sharp; Lindsay Semple; R Andrew Seaton
Journal:  J Antimicrob Chemother       Date:  2013-03-08       Impact factor: 5.790

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.